Univercells

Belgium
Gozée, Wallonia, Belgium, 6041

Company profile

Univercells company profile

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.

Business identity

Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
6041
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
11
Total equity funding
$232.3M
Last funding
Series D / $43.3M / 2022-10-17
Last equity funding
Series D / $43.3M
Investors
20
Lead investors
7
Founders
2
Articles
32

Founders and investors

Founders

Hugues BultotJosé Castillo

Lead investors

Adjuvant CapitalBill & Melinda Gates FoundationHTHSFPI-FPIMS.R.I.W.Takeda VenturesWalloon

Investors

AdBio partnersAdjuvant CapitalBill & Melinda Gates FoundationFarallon Capital ManagementKohlberg Kravis Roberts & Co.